These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26410807)

  • 1. Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation.
    Renukaradhya GJ; Narasimhan B; Mallapragada SK
    J Control Release; 2015 Dec; 219():622-631. PubMed ID: 26410807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery.
    Griffin JF
    Adv Drug Deliv Rev; 2002 Oct; 54(6):851-61. PubMed ID: 12363434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.
    Calderon-Nieva D; Goonewardene KB; Gomis S; Foldvari M
    Drug Deliv Transl Res; 2017 Aug; 7(4):558-570. PubMed ID: 28639138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-based subunit nanovaccines.
    Skwarczynski M; Toth I
    Curr Drug Deliv; 2011 May; 8(3):282-9. PubMed ID: 21291373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of animal models in the development of human vaccines.
    Gerdts V; Littel-van den Hurk Sv; Griebel PJ; Babiuk LA
    Future Microbiol; 2007 Dec; 2(6):667-75. PubMed ID: 18041907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in peptide-based subunit nanovaccines.
    Skwarczynski M; Toth I
    Nanomedicine (Lond); 2014 Dec; 9(17):2657-69. PubMed ID: 25529569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.
    van Riet E; Ainai A; Suzuki T; Kersten G; Hasegawa H
    Adv Drug Deliv Rev; 2014 Jul; 74():28-34. PubMed ID: 24862579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
    Sharma R; Agrawal U; Mody N; Vyas SP
    Biotechnol Adv; 2015; 33(1):64-79. PubMed ID: 25499178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
    Marasini N; Kaminskas LM
    Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery.
    Mehrabi M; Montazeri H; Mohamadpour Dounighi N; Rashti A; Vakili-Ghartavol R
    Arch Razi Inst; 2018 Sep; 73(3):165-176. PubMed ID: 30280836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle vaccines.
    Zhao L; Seth A; Wibowo N; Zhao CX; Mitter N; Yu C; Middelberg AP
    Vaccine; 2014 Jan; 32(3):327-37. PubMed ID: 24295808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant-made oral vaccines against human infectious diseases-Are we there yet?
    Chan HT; Daniell H
    Plant Biotechnol J; 2015 Oct; 13(8):1056-70. PubMed ID: 26387509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers of antigen proteins for vaccine delivery.
    Lopes Chaves L; Dourado D; Prunache IB; Manuelle Marques da Silva P; Tacyana Dos Santos Lucena G; Cardoso de Souza Z; Muniz Mendes Freire de Moura P; Nunes Bordallo H; Rocha Formiga F; de Souza Rebouças J
    Int J Pharm; 2024 Jun; 659():124162. PubMed ID: 38663646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Based Vaccines Against Respiratory Viruses.
    Al-Halifa S; Gauthier L; Arpin D; Bourgault S; Archambault D
    Front Immunol; 2019; 10():22. PubMed ID: 30733717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanovaccines against Animal Pathogens: The Latest Findings.
    Celis-Giraldo CT; López-Abán J; Muro A; Patarroyo MA; Manzano-Román R
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of nanoparticle-based vaccines.
    Marasini N; Skwarczynski M; Toth I
    Expert Rev Vaccines; 2014 Nov; 13(11):1361-76. PubMed ID: 25155636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanostructure vaccines: applications and challenges.
    Simón-Vázquez R; Peleteiro M; González-Fernández Á
    Expert Opin Drug Deliv; 2020 Jul; 17(7):1007-1023. PubMed ID: 32476491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanovaccines: A game changing approach in the fight against infectious diseases.
    Priyanka ; Abusalah MAH; Chopra H; Sharma A; Mustafa SA; Choudhary OP; Sharma M; Dhawan M; Khosla R; Loshali A; Sundriyal A; Saini J
    Biomed Pharmacother; 2023 Nov; 167():115597. PubMed ID: 37783148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview on the role of silica-based materials in vaccine development.
    Navarro-Tovar G; Palestino G; Rosales-Mendoza S
    Expert Rev Vaccines; 2016 Nov; 15(11):1449-1462. PubMed ID: 27160927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.